General Info
MEDA Angels is a healthcare-focused angel investor group comprised of accredited investors with diverse backgrounds. They have made 8 investments, with the latest one in MimiVax as part of their Series C. The group is based in Washington, DC, United States.
Location:
Country: United States of America
Industries: Not available
Investment Regions: EU, NA
Investment Stages: pre-seed, seed
Website: https://medaangels.com/
angel-individual
EU, NA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: PR Newswire reports MEDA Angels invested in MimiVax on Jan 9, 2024. Counting from that date: as of Nov 1, 2025, the last known investment was 21 months and 23 days ago, which exceeds 12 months. However, PitchBook shows a MimiVax deal dated May 22, 2025 listing MEDA Angels as an investor; this indicates a more recent investment on May 22, 2025. Counting from May 22, 2025 to Nov 1, 2025 is 5 months and 10 days, which is less than 6 months, placing them in the highest activity bracket. The invested startup name: MimiVax. Sources: PR Newswire Jan 9, 2024 mention and PitchBook deal record May 22, 2025.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Meda Angels
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI